H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act, introduced by Reps. Chris Smith (NJ) and Doris Matsui (CA), reauthorizes the Stem Cell Therapeutic and Research Act of 2005.
Chris Smith: “H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act, introduced by Reps. Chris Smith (NJ) and Doris…”
Editor's note · Context
Smith discusses the reauthorization of a key stem cell research act.
Share
More from Chris Smith
Under the constant threat of Russian aggression, interference, and disinformation, and with the prospect of EU membership hanging in the balance, there is much at stake for our partners in Moldova and for the United States in a region that…
Our goal with that assistance was to help Moldova break its decades-long dependence on Russia when it comes to the energy assistance.
This bill is going to lead to exploitation of minors, exploitation of children.
I wish to underscore my strong support of H.R. 23, the Illegitimate Court Counteraction Act, and highlight the immediate need to sanction the International Criminal Court (ICC) for its dangerous abuse of power and for the United States to…





